A study from the University of Washington Seattle studied the incidence of Graves’ disease before and after receiving the COVID-19 vaccine, determining no significant difference. Researchers also looked at levels of thyroid antibodies in the blood of patients with Graves’ hyperthyroidism before and after vaccination and found no significant difference.
Read More »A recent study cited in Lupus Science and Medicine covered vaccine safety in patients with Systemic Lupus Erythematosus. 237 vaccinated SLE participants were included, and researchers found that rates of vaccine side effects reported by those with SLE were statistically similar to those in the general public; additionally, the majority of patients did not experience disease flare-ups in response to vaccination.
Read More »A study published in Neurology Neuroimmunology & Neuroinflammation examined the safety of COVID-19 vaccines in people with multiple sclerosis (MS). The COVER-MS study funded by the National MS Society used an online self-reporting database called iConquerMS to gather information from 719 adults with MS and record information on vaccine side effects. In addition, they were also able to compare the effects of vaccines from different manufacturers and various MS therapies.
Read More »A recent article published by Science Insider discussed a new concern about COVID-19 vaccine side effects colloquially termed “Long Vax.” There have been rare reports of people developing symptoms of small fiber neuropathy (SFN) and/or postural orthostatic tachycardia syndrome (POTS) following vaccination for COVID-19. These conditions lead to persistent headaches, fatigue, and problems with heart rate and blood pressure, similar to those developed in cases of Long Covid.
Read More »